Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Factors Impacting Its Occurrence and Treatment Options for a Better Management
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Université Claude Bernard Lyon 1), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Youcef Chelghoum(Hôpital Edouard Herriot), Xavier Thomas(Hôpital Lyon Sud), Mohamed Sobh(Hospices Civils de Lyon), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière(Hôpital Lyon Sud), Marie Y. Detrait(Hôpital Civil de Charleroi)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547